These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33909646)

  • 1. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
    Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
    Rathe JA; Hemann EA; Eggenberger J; Li Z; Knoll ML; Stokes C; Hsiang TY; Netland J; Takehara KK; Pepper M; Gale M
    J Infect Dis; 2021 Apr; 223(7):1120-1131. PubMed ID: 33367830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area.
    Cassaniti I; Percivalle E; Sarasini A; Cambiè G; Vecchio Nepita E; Maserati R; Ferrari A; Corcione A; Di Martino R; Bonetti A; Di Napoli A; Ferrari G; Baldanti F
    Clin Microbiol Infect; 2021 Jun; 27(6):914.e1-914.e4. PubMed ID: 33677083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
    Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
    Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.
    Nesbitt DJ; Jin DP; Hogan JW; Yang J; Chen H; Chan PA; Simon MJ; Vargas M; King E; Huard RC; Bandy U; Hillyer CD; Luchsinger LL
    BMC Infect Dis; 2021 Aug; 21(1):871. PubMed ID: 34433423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.
    Tuite AR; Fisman D; Abe KT; Rathod B; Pasculescu A; Colwill K; Gingras AC; Yi QL; O'Brien SF; Drews SJ
    Microbiol Spectr; 2022 Feb; 10(1):e0256321. PubMed ID: 35196819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
    Stadlbauer D; Tan J; Jiang K; Hernandez MM; Fabre S; Amanat F; Teo C; Arunkumar GA; McMahon M; Capuano C; Twyman K; Jhang J; Nowak MD; Simon V; Sordillo EM; van Bakel H; Krammer F
    Nature; 2021 Feb; 590(7844):146-150. PubMed ID: 33142304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
    Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of serological assays for identifying high titer convalescent plasma.
    Farnsworth CW; Case JB; Hock K; Chen RE; O'Halloran JA; Presti R; Goss CW; Rauseo AM; Ellebedy A; Theel ES; Diamond MS; Henderson JP
    Transfusion; 2021 Sep; 61(9):2658-2667. PubMed ID: 34216156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
    Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S
    Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
    Saeed S; O'Brien SF; Abe K; Yi QL; Rathod B; Wang J; Fazel-Zarandi M; Tuite A; Fisman D; Wood H; Colwill K; Gingras AC; Drews SJ
    PLoS One; 2021; 16(9):e0257743. PubMed ID: 34555095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina.
    Ojeda DS; Gonzalez Lopez Ledesma MM; Pallarés HM; Costa Navarro GS; Sanchez L; Perazzi B; Villordo SM; Alvarez DE; ; Echavarria M; Oguntuyo KY; Stevens CS; Lee B; Carradori J; Caramelo JJ; Yanovsky MJ; Gamarnik AV
    PLoS Pathog; 2021 Jan; 17(1):e1009161. PubMed ID: 33444413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers.
    Najimi N; Tajount L; Regragui Z; Remz C; Ait-Lhaj-Mhand R; Kadi C; Belayachi L; Seghrouchni F; Nadia Dakka ; El Hassani RA; Elharti E; Oumzil H; Bakri Y
    Int J Immunopathol Pharmacol; 2024; 38():3946320241260633. PubMed ID: 38836458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
    Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
    Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of SARS-CoV-2 seroprevalence estimates between commercial lab serum specimens and blood donor specimens, United States, September-December 2021.
    Kao S-YZ; Nycz E; Benoit TJ; Clarke KEN; Jones JM
    Microbiol Spectr; 2024 Aug; 12(8):e0012324. PubMed ID: 38869287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.
    Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y
    Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.